Join
Live feed
·
INSIDERFilingvia Quantisnow
First Tracks Biotherapeutics Inc. logo

Director Orwin John A converted options into 6,030 shares, increasing direct ownership by 57% to 16,695 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TRAX· First Tracks Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAX (First Tracks Biotherapeutics Inc.) and more on Quantisnow.